CedeƱo, Prince Kurt G.
HRN: 21-47-62 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/21/2022
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
06/21/2022
06/27/2022
IV
480mg
Q6h
T/c Aspiration Pneumonia R/o CNS Infection
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Non-compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes